Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/2007
12/21/2007CA2653657A1 Process for making n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide and starting materials therefor
12/21/2007CA2650263A1 Polymorphs of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
12/20/2007US20070293668 Phenylindoles for the treatment of HIV
12/20/2007US20070293558 Ophthalmic Compositions for Treating Ocular Hypertension
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
12/20/2007US20070293519 Analogs of thalidomide as potential angiogenesis inhibitors
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293470 Carboxamide Spirolactam Cgrp Receptor Antagonists
12/20/2007US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/20/2007US20070292485 Polyol ester compounds
12/20/2007DE102006027535A1 Dispersionsfarbstoffe, ihre Herstellung und ihre Verwendung Disperse dyes, to their preparation and their use
12/19/2007EP1867684A1 Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element
12/19/2007EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents
12/19/2007EP1866984A1 Composite material, light emitting element and light emitting device
12/19/2007EP1866327A1 Improved process for preparation of highly pure trandolapril
12/19/2007EP1866300A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists
12/19/2007EP1865949A2 Modulators of atp-binding cassette transporters
12/19/2007EP1778636B1 Oxime ester photoinitiators
12/19/2007EP1740538A4 Bicyclic heterocycles useful as serine protease inhibitors
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007EP1005341B1 Il-8 receptor antagonists
12/19/2007CN101090896A Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
12/19/2007CN101090887A Anthracene derivative, light emitting element using the same, and light emitting device using the same
12/19/2007CN101090886A Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid
12/19/2007CN101090883A Substituted hydroxyethylamines
12/18/2007US7309799 Asymmetric reaction of a cyclopropane carboxylic acid, ester, or amide or lactone or lactam with a phthalimide: potassium phthalimide; products are enantiomerically enriched
12/18/2007US7309787 2-Substituted spiro[cyclopropane-1,3'-indolin-2'-ones]: morpholinylphenyl-, piperidinylethylphenyl-, 3-(carboxyethyl)-4-methylpyrrol-2-yl-, pyrazolon-2-yl-, 4-methylimidazol-5-yl-; vascular endothelial growth factor inhibitors; regulate, modulate and/or inhibit abnormal cell proliferation
12/18/2007US7309717 Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
12/18/2007US7309716 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
12/18/2007CA2378087C New process for the preparation of n-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis-[2-(4-morfolino)ethoxy]-2'-oxospiro[cyclohexan-1,3'-[h]indol]-1'(2'h)-yl]-sulfonyl]-3-methoxybenzamideand its salts
12/13/2007WO2007141283A2 Salts and crystalline salt forms of an 2-indolinone derivative
12/13/2007WO2007127763A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/13/2007WO2007109211A3 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses
12/13/2007WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
12/13/2007US20070287825 Constrained cis-diol-borate bioconjugation system
12/13/2007US20070287735 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
12/13/2007US20070287732 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection
12/13/2007US20070287715 e.g.5-(4-tert-Butylphenyl-1-(4-(2-carboxypropan-2-yloxy)phenyl)indole-2-carboxylic acid ; inhibition of the activity of microsomal prostaglandin E synthase-1, 5-lipoxygenase-activating protein (FLAP); respiratory system disorders
12/13/2007US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent
12/13/2007US20070285004 Arylamine Compound and Organic Electroluminescent Device
12/13/2007CA2653527A1 New salts and crystalline salt forms of an indolinone derivative
12/12/2007EP1864973A1 Process for the preparation of perindopril and salts thereof
12/12/2007EP1863762A1 Indole derivatives and methods of using the same
12/12/2007EP1863464A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
12/12/2007EP1268481B1 Kinase inhibitors as therapeutic agents
12/12/2007CN101087781A Indole derivatives for treating pulmonary tuberculosis
12/12/2007CN101087768A Thrombopoietin activity modulating compounds and methods
12/12/2007CN101087758A Indole derivatives useful as progesterone receptor modulators
12/12/2007CN101085757A Method for forming compound with indole truss by catalytic reaction
12/12/2007CN100354281C Process for preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3] benzotiazepines
12/12/2007CN100354279C Novel camptothecin derivatives and their preparation process and use
12/12/2007CN100354261C Process for the preparation of 1,1,3,3-tetraalkylisoindolines starting from n-benzylphthalimide
12/11/2007US7307099 Thioredoxin/thioredoxin reductase inhibitors, antiproliferative agents, anticancer agents
12/11/2007US7307098 Indole derivatives and drugs containing the same
12/11/2007US7307088 Substituted anthranilic amide derivatives and methods of use
12/11/2007US7307044 Use as insecticides, fungicides and/or herbicides; e.g. 3-(2-methyl-5-(4-chloro-phenyl)phenyl)-3-chloro-5,5-dimethyl-pyrrolidin-2,4-dione
12/11/2007US7307037 Metallic catalysts for chemo-, regio- and stereoselective reactions, and corresponding precursors
12/06/2007WO2007140195A2 Methods and systems for increasing production of equilibrium reactions
12/06/2007WO2007139499A1 Compounds for use as a medicament
12/06/2007WO2007139464A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer
12/06/2007WO2007139002A1 Method for producing nitrogen-containing fused ring compound
12/06/2007WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound
12/06/2007WO2007138611A1 3-(heterocyclyl)-n-(arylsulfonyl)indole derivatives as functional 5-ht6 ligands
12/06/2007WO2007138282A2 Bi-aryl or aryl-heteroaryl substituted indoles
12/06/2007WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007WO2007113680A3 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
12/06/2007WO2007061768A3 Fluorescent membrane intercalating probes and methods for their use
12/06/2007WO2006110804A3 Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules
12/06/2007US20070282111 An aryl compound with an active group is reacted with an amine compound in the presence of a base by means of a catalyst which comprises a palladium compound having a tertiary phosphine group and a phase-transfer catalyst; highly selective and efficient
12/06/2007US20070281934 Indole derivatives as inhibitors of histone deacetylase
12/06/2007CA2653054A1 Methods and systems for increasing production of equilibrium reactions
12/06/2007CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/05/2007EP1862442A1 Process for oxidation of organic compounds
12/05/2007EP1862179A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor
12/05/2007EP1861392A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
12/05/2007EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors
12/05/2007EP1861379A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
12/05/2007EP1861368A1 Process for the preparation of 2-azabicycloý3.3.0¨octane-3-carboxylic acid derivatives
12/05/2007EP1861367A1 An improved process for the purification of perindopril
12/05/2007EP1861366A2 Mitotic kinesin inhibitors
12/05/2007EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
12/05/2007EP1638544B1 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
12/05/2007EP1554262B1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
12/05/2007EP1433479B1 Appetite-stimulating agents and remedies for anorexia
12/05/2007EP1169294B1 Pharmaceutical compounds
12/05/2007CN101084209A Compounds with Kv4 ion channel activity
12/05/2007CN101084190A 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists
12/05/2007CN101084189A Indol derivatives as inhibitors of soluble adenylyl cyclase
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007CN100352816C Nociceptin analogs
12/05/2007CN100352805C Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction
12/04/2007US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives
12/04/2007US7304048 For use as anti-inflammatory agents
12/04/2007CA2378082C Process for the preparation of spiro[cis-4-(.beta.-hydroxyethyloxy)cyclohexane-[3h]indol]-2'[1'h]one derivatives